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Summary:
Graft-vcrsus-host reactions are mediated by subpopula-
iions of donor Τ cells and can be attributed to host specific
minor histocompatibility (niH) antigens. We isolated
strong anti-host mH antigen proliferative Τ cell lines,
LG2, PN2, and LH3, from three patients suffering from
acute graft-versus-host disease (GVHD). To study the role
of the different major histocompatibility complex (MHC)
molecuies in the anti-host mH antigen specific proliferative
response, the reactivities of the three Τ cell lines were
analysed in primed lymphocyte test (PLT) assays against
panels of stimulator cells obtained from unrelated blood
donors. LG2 and LH3 stimulating determinants were
commonly detected in the unrelated panel, whereas the
PN2 Τ cell line recognized a rare specificity. The responses
were associated with the presence of seif HLA-DR mole-
cules on the stimulator cells, although not all DR sharing
stimulator cells were recognized. The proliferative res-
ponses of LG2, LH3 and PN2 cells could be blocked by
monoclonal antibodies (MoAbs) against HLA-DR, but not
by MoAbs against HLA-A/B/Cw, HLA-DQ or -DP. At
the responder cell level, depletion of CD4 cells as well as
blocking with CD4 specific MoAbs abrogated the specific
responses of the three Τ cell lines. Our findings suggest
that anti-host Th cell responses activatcd in the acute
phase of GVHD are directed against both frequent and
rare mH antigens, are mediated by CD4 + ve class II
restricted Th cells, and use the HLA-DR molecule as a
conimon restriction element for mH antigen presentation.
specific cytotoxic Τ cell (CTL) responses in patients
suffering from GVHD ^ The role of MHC class II
antigens, which are clearly induced on the target tissues
of GVHD8 9, as restriction molecules in the cellular anti-
host response IS as yet not defimtely ldentified Reins-
moen et al reported that Τ cells isolated from affected
skin lesions of patients with acute GVHD and specifi-
cally proliferatmg to host but not donor cells, were most
probably restricted by products of the HLA-D region l0
Although the latter study mcluded a small number of
cases lt mdicated the functional role of both proliferative
Τ lymphocyte (Th) cells and MHC class II antigens in
local GVH reactions In line with this observation, we
recently demonstrated in 16 patients that anti-host Th
cell responses isolated from the patients' penpheral
blood were significantly higher in patients having acute
GVHD than m patients without GVHD " Assuming
that these anti-host proliferative responses would be
MHC class II restricted, we aimed m this study to define
whether a particular MHC class II molecule dommated
as the restriction determmant From three patients suf-
fering from acute GVHD, Τ cell lines with prohferating
capacity against host but not donor cells were estabhshed
and the mH antigen specificity of these Τ cell lines was
analysed m the patients' famihes and in the unrelated
population Using monoclonal antibodies (MoAbs) spe-
cific for HLA-DR, -DQ, or -DP molecules and highly
punfied Τ cell subsets obtained by antibody-coated mag-
netic beads, we ldentified the major phenotype and MHC
restriction determmant usage of the Th cells activated in
the acute phase of GVHD
Minor histocompatibility (mH) antigen dispanties
between donor and recrpient may mcrease the nsk of
graft-versus-host disease (GVHD) after allogeneic HLA
genotypically identical bone marrow transplantation
(BMT) ' 3 In the anti-host Τ cell reaction, presumably
directed against several mH antigens, both major histo-
compatibility complex (MHC) class I and II seif antigens
serve as presentmg molecules for mH antigens to sub-
populations of donor Τ cells MHC class I products
function as major restriction molecules for mH antigen
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Materials and methods
Patients
Patients LG, PN and LH underwent non-T cell-depleted
BMT from their HLA-identical MLC non-reactive sib-
hng donors as treatment for acute myeloid leukemia The
preparative regimen was total body Irradiation (8 Gy)
and cyclophosphamide (60 mg/kg/ χ 2) To prevent acute
GVHD, patients received cyclosponn Α (CSA), started
on day — 1 as a contmuous infusion (3 mg/kg/day)
followed by oral administration (9 mg/kg/day) The dose
of CSA was adjusted aecording to the chnical course,
renal function and plasma concentration, tapered off
slowly over a penod of months, and discontmued at 3-4
366 C A C M VAN ELS et al
months after BMT Acute GVHD was diagnosed at day
12 for patient LG (grade III), at day 11 for patient PN
(grade III), and at day 12 for patient LH (grade I), and
was treated with high dose methylprednisolone
Blood samples
Hepannized blood samples were obtamed from patients
before and after BMT, from siblmg marrow donors,
family members and unrelated healthy blood donors
Penpheral blood lymphocytes (PBL) were isolated by
Ficoll-Isopaque density gradient centnfugation, washed
and resuspended in 10% RPMI-1640-dimethylsulfoxide
for cryopreservation in liquid nitrogen The HLA typing
of the three patients was as follows, patient LG HLA-
Al, -A3, -B7, -B8, -Cw7, -DR2, -DR3, -DQwl, -DPw4,
patient PN HLA-A3, -A32, -B7, -B44, -Cw7, -DR2,
-DQwl, -DQw2, -DP4, and patient LH HLA-A2, -A3,
-B7, -B37, -Cw6, -Cw7, -DRw6, -DRwlO, -DPw2 Ohgo-
nucleotide typing for HLA-DR2 subtypes Dw2, Dwl2
and Dw21 was performed by techniques essentially as
descnbed by Kenter et al n The DR2 B5 genes, carrying
the allele specific sequences of Dw2, Dwl2 and Dw21
were amplified using a set of selected pnmers Hybndiza-
tion occurred with the following ohgonucleotides,
DRB5001, specific for nucleotide residues 109-128
(DRB5) of Dw2, Dwl2 and Dw21, DRB5002, specific
for nucleotide residues 190-209 (DRB5) of Dw2, and
DRB5003, specific for nucleotide residues 161-180
(DRB5) of Dwl2 and Dw21
Tissue culture medium
The cell cultures were performed in RPMI-1640 supple-
mented with antibiotics (gentamicin) and either 15%
heat inactivated human serum (T cell lines and prolifera-
üon assays) or 10% fetal calf serum (Epstem-Barr virus
transformed Β cell hnes [EBV-LCL])
Τ cell hnes
Anti-host prohferative Τ cell hnes 'LG2, PN2, and LH3'
were mitiated with PBL obtained from patient LG at 90
days post-BMT, from patient PN at 43 days post-BMT,
and from patient LH at 92 days post-BMT The cells
were used as responder cells and were cultured with
30 Gy irradiated patients' pre-BMT PBL at a ratio of
1 x 106 post-BMT PBL for 1 χ 106 irradiated pre-BMT
PBL At day 6, these cells were specifically restimulated
with pre-BMT PBL in the presence of 2% highly punfied
IL-2 (Lymphocult-HP, Biotest) Thereafter, the Τ cell
hnes were grown by weekly addition of specific feeder
cells alternated by fresh medium contaimng 15% IL-2
(Lymphocult-T, Biotest)
Prohferation assay
Responder cells, 5-10 x 103, were cultured with 105 20 Gy
irradiated PBL or with 2 5 x 104 75 Gy irradidted EBV-
LCL in flat bottom microtiter plates for 64 h Sixteen
hours before harvesting the cultures were labeled with
1 μ θ tntiated thymidme Isotope incorporation was
measured in a liquid scintillation counter The results
(ι e mean c ρ m of tnphcate cultures) are either
expressed as % of relative response (RR),
RR = cpm expenmental-cpm of respondersalonc — x 100%
cpm in presence ofhost cells - c p m of responders alone
or as Stimulation index (SI)
„ · _ c p m expenmental
cpm responders alone + c ρ m stimulators alone
SI equal to or greater than 3 are considered as positive
Monoclonal antibodies
The antibodies OKT3, OKT4, and OKT8 react with
CD3, CD4, and CD8 Τ cell markers respectively (pur-
chased from Ortho) The antibody W6/32 (obtained
from Sera-Lab Ltd, Sussex) recognizes an HLA-class I
monomorphic determinant The antibodies PdV5 2, and
B8 11 2 were produced in our department and are spe-
cific for a conformational determinant of HLA-DR/DQ/
DP and HLA-DR respectively 13 Antibody SPV-L3 IS
reactive with HLA-DQ (kmdly provided by Dr Η Spits,
DNAX, Palo Alto, CA), antibody B7/21 is specific for
HLA-DP (Beckton and Dickinson)
Fluorescence analysis
Τ cell hnes were stained for CD3, CD4, and CD8
expression by a Standard double immunofiuorescence
technique, using phycoerythrin or fluorescein lsothiocya-
nate conjugated CD3 (Leu4), anti-CD4 (Leu3a), and
anti-CD8 (Leu2a) monoclonal antibodies The samples
were assayed on a fluorescence activated cell sorter
Separation of Τ cell subsets
CD4 and CD8 Τ cell subsets were separated by positive
and negative selection using antibody-coated monosized
magnetic microspheres (Dynabeads, Dynal) l 4 Bnefly, 2—
3 x ΙΟ6 Τ cells were incubated with CD4- or CD8-coated
beads at a beads to cell ratio of 20 1 at 4°C and left for 2 h
while rotating Then, positive and negative fractions
were obtained using a magnetic device Posifively
selected cell fractions were used in the primed lympho-
cyte test without interference of attached beads l 5
Τ cell clones
Three anti-HLA-class II reactive Τ cell clones specific for
HLA-DR2 (clone 2616), HLA-DQwl (clone 2604) and
HLA-DPw3 (clone 2712), kindly provided by Dr Α
Termijtelen, were used as control reagents in blocking
assays
Results
Generation oj LG 2, PN2, and LH3 cells in acute phase
οf GVHD
Τ cell hnes LG2, PN2 and LH3 were induced from three
patients suffenng from acute GVHD by Stimulation of
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Table I Prohferative responses of LG2, PN2, and LH3 cells m the presence of stimulator cells
collected from specific hosts, bone marrow donors, related and unrelated blood donors
Cell hne
LG2
PN2
LH3
Stimulator ceü^ from
Bone marrow recipient LG
Bone marrow donor DG
HLA-haploidentical sibhng CG
Bone marrow recipient PN
Bone marrow donor JN
HLA-haploidentical siblmg GN
Bone marrow recipient LH
Bone marrow donor DH
HLA-identical blood donor RV
cpm ±SD
6322 ±1075
100±20
19 886 ±3579
10217±1533
100±13
23 273 ±233
45 084 ±496
717±93
10255± 103
RR"
100
2
323
100
I
230
100
1
22
•Stimulator cells were EBV-LCL [LG, DG, PN, LH, DH] or PBL [CG, GN, RV]
b% relative response The positive reactions (RR>20%) are in ltahcs
their post-BMT lymphocytes with irradiated patients'
pre-BMT cells as outlined in Materials and Methods.
After the third and following stimulations, the Τ cell lines
showed specific proliferative responses in PLT assays in
the presence of pre-BMT patients' cells without prolifer-
ating significantly in the presence of cells of their bone
marrow donors (Table I). As indicated in Table I,
significant responses of LG2 and PN2 cells could also be
induced with cells from an HLA haplo-identical sibling
CG (LG2) and GN (PN2); LH3 cells responded in the
presence of cells from an unrelated HLA-A, -B, -Cw,
-DR matched donor RV.
Anti-host Th cell lines proliferate in the presence of
allogeneic DR-sharing stimulator cells
Since pre-BMT patients' cells were not the only cells
stimulating LG2, PN2, and LH3, further assays were
performed to define the MHC restriction determinants
and specificities of these Th cell lines. LG2, PN2, and
LH3 cells were tested against a panel of more than 30
healthy unrelated donors. The results (Table II) show
that among the 20 donors who share HLA-DR2, or
-DR3 with LG2, 13 could stimulate these cells. Although
no seif HLA specificities other than HLA-DR (i.e. HLA-
A, -B, -Cw, -DQ, -DP) were found to be associated with
positive responses of LG2 (not shown), two out of 11
non-DR2 or -DR3 positive donors (i.e. JM and HA)
were able to stimulate LG2 cells. The latter two stimula-
tor cells shared DPw4 with LG2.
As is shown in Tables III and IV, only HLA-DR
matched panel donors were able to stimulate PN2 and
LH3 cells. Of the 18 donors sharing DR2 with PN2 cells
only three were stimulatory; non-DR-sharing cells
(«=18) did not stimulate (Table III). Α higher panel
reactivity was found for LH3 cells when tested against 24
Table II Frequency analysis and MHC restriction element usage of LG2
Stimulations
Α Controls
Β DR sharing
C DR non-shanng
Patient LG (n = 6")
Donor DG(« = 6)
KL
KV
ST
PH
HE
GO
GI
GJ
DB
NY
JE
BL
AA
n=5"
n-=2
JM
HA
n = 9
HLA-DR
2,3
2,3
2,v/6<
2,5
i,w6
2
2,w6
3,4
3,3
2M
2,W6
3,4
1,3
3M
3
2
7,8
l.wlO
non 2,3
SI"
27 4 ±10.8
0 8±0.2
26 6
20.5
127 6
1416
100 3
20 4
10 1
52
12 7
305 8
122 2
16 7
10.5
14±08
06±05
10 7
38.3
1 8±1 1
'Stimulation index The positive reactions (SI > 3) are in ltahcs
bNumber of expenments
°HLA-DR sharing with LG2 cells is in ltahcs
dNumber of panel cells tested
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Table III Frequency analysis and MHC restnction eleraent usage of PN2
Stimulators
Α
Β
C
Controls
DR shanng
DR non-shanng
Patient PN (« = 4)b
Donor LN (n = 4)
KL
MB
MA
n=15 c
«=18
HLA-DR
2 (Dw2)c
2 (Dw2)
2 (Dw2),w6d
2 (Dw2),w6
2 (Dw2),wlO
2 (Dw2)
Non2
SI'
76±2 1
07±02
58
58 3
14 0
0 8 ± 0 4
0 6 ± 0 3
"Stimulation index The positive reactions (SI > 3) are in italics
bNumber of expenments
cThe specificities in brackets were determined by ohgonucleotide typing
dHLA-DR shanng with PN2 cells IS in italics
cNumber of panel cells tested
DR-sharing donors; 11 of the DRw6- or DRwlO-shanng
donors stimulated LH3 cells, 14 non DR-sharing donors
were negative (Table IV).
LG2 cells and PN2 cells discnminate between
HLA-identical siblings in the patients'famihes
To further analyse the stimulating determinants, LG2
and PN2 cells were tested against cells from patients'
famihes (no cells were available from family members of
patient LH). As can be deduced from patient LG's
pedigree (Figure 1), LG2 cells discriminated between
various HLA-identical siblings. Thus, LG2 cells specifi-
cally recognized determinant(s) from patient LG (02) but
not from donor DG (03, haplotypes a/c), from sibling 05
but not from sibling 06 (haplotypes a/d), and from
patient's child 52 but not 53 (haplotypes a/r). Cells of the
paüent's mother (00, a/b)) did not stimulate. Paternal
cells were not available for testing.
The reactivity of PN2 cells in the patient's family is
shown in Figure 2. As is clear from this pedigree, PN2
cells discriminated between HLA-identical siblings 02
and 04 (patient and donor, haplocytes b/c), between
siblings 06 and 07 (haplotypes b/d), and between siblings
03, 05, and 09 (haplotypes a/c). The maternal cells (00, a/
b)) were stimulatory as well. Cells of the father were not
available.
LG2, PN2, and LH3 Th cell responses are blocked by
anti HLA-DR and anti-CD4 monoclonal antibodies
Several Mo Abs specific for Τ cell markers CD3, CD4
and CD8, and specific for HLA-A/B/Cw, -DR, -DQ or
-DP backbone structures were tested for their capacity to
inhibit the responses of LG2, PN2 and LH3 cell lines.
The MoAbs (1:100, 1:400; 1:1600) as well as the re-
sponder cells were tested at different concentrations
(data not shown). From representative experiments
Table IV Frequency analysis and MHC restnction element usage of LH3
Stimulators
Α Controls
Β DR sharing
C DR non-shanng
Patient LH (« = 2)b
Donor DH (n = 2)
JB
IZ
ST
BR
BD
TU
GU
RV
VD
GO
NK
«=10"
n = 3
«=14
HLA-DR
w6,wlO
w6,wlO
2,w<5<
4,wlO
3,w6
3,w6
7,wl0
5,wl0
5,w6
w6,w!0
4, wo
2,w6
5,w6
w6
wlO
Non w6,wlO
SI'
7 2±1 1
1 7 ± 1 0
78
35 4
40
40
112
112
116
25 0
92
5 1
10 3
1 3 ± 0 9
1 6 ± 0 4
1 5±1 1
•"Stimulation index The positive reactions (SI > 3) are in italics
'Number of expenments
CHLA-DR shanng with LH3 cells is in italics
dNumber of panel cells tested
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Figure 1 Prohferation pattern of LG2 cells in patient LG's family
Underlmed responses represent positive reactions (Sl > 3) P, patient,
D, marrow donor M, mother The HLA haplotypes are as follows a,
A1,B8,DR3, b, A29,B44,DR8, c, A3,B7,DR2, d, A1,B7,0R2,
ρ, A3,B7, DR2,q, Al,B8,DR3,r, A2,B44,DR4
Sl
02 03
cd
NT
bc(P)
Sl 45 7
ac
05
08 — 09
ac
70
Figure 2 Prohferation pattern of PN2 cells m patient PN's family
Underlmed responses represent positive reactions (Sl > 3) P, patient,
D, marrow donor M, mother The HLA haplotypes are as follows a,
A29,B44,DR7,b, A32,B44,DR2,c, A3,B7,DR2,d, A3,B44,0R5
shown m Table V we can conclude that the OKT3
anübody (CD3) was a potent Inhibitor of LG2, PN2, and
LH3 responses, as well as the antibodies OKT4 (CD4),
PdV5 2 (HLA-DR, -DQ, -DP), and B8 11 2 (HLA-DR)
No blockrag of LG2, PN2, and LH3 responses was
observed in the presence of the antibodies OKT8 (CD8),
wo/32 (HLA-A, -B, -Cw), SPV-L3 (HLA-DQ) and B7/21
(HLA-DP)
LG2 and PN2 prohferative responses are mediated by
the CD4+ population
FACS analysis of the LG2 and PN2 cultures revealed
fluctuations in their CD4/CD8 subset constitution,
depending on the number of restimulation cycles of the
lmes To define the Τ cell subset responsible for the
prohferative activity, Τ cell subset depletion studies using
CD4 or CD8 antibody coated dynabeads were per-
formed Separation using CD8 coated beads yielded in
all cases 98-100% pure populations of CD4 + cells as the
negaüvely selected fraction In the positively selected
fraction, thus containmg all the CD8 + cells, a variable
non-specific bmding of CD4 + cells could be observed
(1-29%), which appeared to depend on the viabihty of
the cell cultures Representative expenments using CD8
coated beads (Table VI, expts 1-5) indicate that the
prohferative responses of PN2 and LG2 could be attn-
buted to the highly pure negaüvely isolated CD4 +
fractions and not to the CD8 ennched positively selected
fractions, even m a case where the unseparated cell hne
was not ltself responsive (expt 4) To exclude the possi-
bihty that CD8+ cells did not respond due to the
presence of the dynabeads, we also performed a cell
Separation with CD4 coated dynabeads (expt 5) The
prohferative response of the CD4+ fraction was not
inhibited by the presence of the beads, whereas no
response of the CD8 + fraction was found in the absence
of beads
Table V Inhibition of prohferation of Th cell lmes LG2, PN2 and LH3
Monoclonal antibody
None
OKT3
OKT4
OKT8
w6/32
PdV5 2
B8 U 2C
SPV L3C
B7/21'
Specifiaty
CD3
CD4
CD8
HLA-A,-B, - C w
HLA-DR, - D Q , - D P
HLA-DR
HLA-DQ
HLA-DP
Expt 1
100"
8
50
114
76
21
17
111
115
LG2
Expt 2
100
5
47
139
124
—
29
146
—
Responder cells
Expt
100
20
11
110
84
13
3
106
97
PN2
3 Expt 4
100
—
18
96
80
6
1
103
114
Expt
100
9
16
89
81
—
19
77
—
LH3
5 Expt 6
100
7
31
102
84
16
86
96
"Prohferation was raeasured in the presence of specific stimulator cells ι e EBV-LCL from patient LG (Expts 1,2), PBL from
blood donor MA (Expts 3, 4), and EBV-LCL from patient PN (Expts 5, 6)
bRelatwe responses measured m the absence of MoAbs (100%) were 41 580 c ρ m (Expt 1), 21 797 c ρ m (Expt 2),
14481cpm (Expt 3), 14 682 c ρ m (Expt 4), 45 657 c ρ m (Expt 5), and 38 100c ρ m (Expt 6) RR < 75% in the presence of
MoAbs (1 300) represent Inhibition (m italics)
T h e MoAbs SPV-L3 and B7/21 significantly inhibited the prohferative responses of two control alloreactive Τ cell clones
specific for HLA-DQ and HLA DP respectively, whereas MoAb B8 11 ? did not aspecifically block these clones (data not
shown)
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Table VI Functional analysis of PN2 and LG2 lsolated Τ cell subsets
Expt Cell line
PN2
PN2
LG2
LG2
LG2
Method of selectwn
None
CD8 beads + fraction
CD8 beads — fraction
None
CD8 beads + fraction
CD8 beads - fraction
None
CD8 beads + fraction
CD8 beads-fraction
None
CD8 beads + fraction
CD8 beads-fraction
None
CD8 beads + fraction
CD8 beads-fraction
CD4 beads + fraction
CD4 beads - fraction
CD4/CD8 sr>
70/29'
1/95
98/2
84/16
7/94
99/<1
83/18
29/71
100/0
15/85«
2/97
99/1
93/7
19/81
100/0
95/5
10/90
28 2
0 6
25 3
6 1
0 9
74
10 2
08
20 7
1 3
10
29 3
9 3
1 5
54
50
1 1
••Percentage of positive cells
•"Stimulation index Responses are measured against host EBV-LCL as stimulator cells
Responses in italics represent positive reactions (SI > 3)
cRemarkable predominance of CD8+ cells
Discussion
The Th cell lines LG2, PN2 and LH3 were generated
from the PBL of three patients suffenng from acute
GVHD after HLA genotypically identical BMT These Τ
cell lines prohferated specifically in the presence of
recipient but not of donor cells Smce the LG2, PN2 and
LH3 cells were mitiated between patients' post-trans-
plant (ι e donor denved) cells as responders and
patients' own pre-transplant cells as stimulators, these Τ
cell lines are almost certainly directed against non-HLA
or mH antigens The findmg that LG2 and PN2 cells
discnminated between vanous HLA-idenücal siblings in
the patients' famihes IS in agreement with the latter
supposition The male specific mH antigen H-Y seemed
not to be mvolved m LG2, PN2 or LH3 recognition,
since female as well as male stimulator cells were recog-
nized (data not shown)
The reactivity patterns of LG2, PN2 and LH3 cells
against a panel of unrelated donors indicated that some,
but not all, HLA-DR matched donors were stimulatory
(Tables I-IV) The role of HLA-DR was further con-
firmed by Inhibition studies using MoAbs (Table V),
only the HLA-DR specific MoAb B8 11 2 and the class
II backbone specific MoAb PdV5 2 could block the LG2,
PN2 and LH3 responses, whereas MoAbs against HLA-
DQ or -DP were inactive On the responder cell level the
HLA-DR restncted mH antigen specific responses
seemed to be mediated exclusively by CD4 + ve Τ cells
This was concluded from the inhibitory effect of anti-
CD4 MoAbs (Table V) and of physical ehmination of
CD4 + ve cells using magnetic beads (Table VI)
The mH antigen determmants defined by LG2 and
LH3 cells were commonly detected in the HLA-DR
matched panel (65% and 46% respectively) In contrast,
the PN2 cells recogmzed only 17% of the HLA-DR2
matched panel donors HLA-DR2 can be divided into
Dw2, Dwl2 and Dw21 subspecificities To test the
possibihty that PN2 cells used a non-frequent Dw sub-
type as a restnction molecule, DR2 subtypmg was per-
formed usmg DR2 subtype specific oligonucleotides It
was found that PN2 cells as well as the majonty of the
panel donors expressed the common Dw2 subtype Thus,
PN2 cells use HLA-Dw2 as a restnction molecule and
are specific for (a) non-frequent mH antigen(s)
The usage of HLA-DR as a restnction determinant for
anti-host prohferative Τ cells isolated from GVHD skin
lesions was reported earlier by Remsmoen et al10 The
HLA-DR restnction molecules identified in our study
were DR2 (LG2, PN2), DR3 (LG2), DRw6 (LH3), and
DRwlO (LH3) Other HLA-DR specificities reported to
be mvolved in mH antigen Th cell responses include
HLA-DR2,16 -DR3, 1 0 ' 6 -DR4,5 and -DR5 17 These ac-
cumulating results point at a rather broad usage of HLA-
DR alleles to present mH antigens to Th cells Neverthe-
less, a possible 'minor' role for other class II molecules
cannot be excluded An earlier study suggested that the
HLA-DP locus could restnct mH antigen responses 10
We observed that LG2 cells were stimulated by the
HLA-DR2 and -3 negative panel donors JM and HA
(Table II), suggesting a role for HLA-DPw4 However,
the host specific prohferative response of LG2 cells could
not be blocked by the HLA-DP specific MoAb B7/21
One possible explanation could be that not HLA-DP
antigens but other as yet non-idenüfied class II determi-
nants may restnct the latter response Another option is
that HLA-DP restncted cells form but a relatively small
part of the LG2 effector cell population, blocking of
which by anti-HLA-DP MoAbs might not significantly
affect the overall response Studies at the clonal level are
currently being undertaken to discnminate between these
possibihties
Anti-mH antigen Th cells are poorly documented in
GVHD Previous in vitro studies on GVH reactions
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mainly emphasized the role of class I restricted mH
antigen-specific CTL.3"7 Recently, however, we found
evidence suggesting that, probably in addition to CTL
activity, ongoing anti-host Th cell activity may be a risk
factor for acute GVHD."· 1 8 Here we show that in three
patients the former reactivity could be mainly attributed
to the recognition of host mH antigens by CD4 + ve post-
BMT recipient cells, and that HLA-DR sharing is a
prerequisite for this response.
The possible significance of our findings may relate to
recent observations that HLA-DR, and also -DQ and
-DP molecules are strongly induced on keratinocytes and
enterocytes in acute GVHD.8·9·19 Therefore, these cells
could act as antigen presenting cells in GVHD. So far,
however, in vitro studies on allo- and hapten specific Τ
cell activation in mouse and man have not been able to
settle this issue because class II positive keratinocytes
either failed to function,20·21 functioned poorly,22·23 or
could only function after Stimulation with interferon
gamma24 as antigen presenting cells. In view of our
present findings, it is tempting to propose that through
the induction of HLA-DR on the target tissues of
GVHD, mH antigens are presented to the patient's
immune system. Hence, local HLA-DR expression may
play a role in the perpetuation of mH antigen specific Th
cells. Yet, very little is known about the identity of the
local target and effector cells involved in GVHD.
Further studies unravelling the cellular mechanisms of
GVHD are needed to define the role of HLA-DR
restricted Th cell responses to mH antigens.
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